Stock Alerts
November 4, 2024 | CNH, Daily JAM, DE, Jubak Picks, Morning Briefing, Stock Alerts, Top 50 Stocks |
Today I added CNH Industrial (CNH) as Pick #7 for my Special Report “10 new stock ideas for an old rally.” I also added the stock to my Jubak Picks Portfolio. Here’s what I wrote:
I like farm equipment maker CNH Industrial for the same reason I own Deere (DE) in my long-term 50 Stocks Portfolio. In the long term the world’s farmers are facing a huge challenge: produce more food as an increasingly chaotic climate makes growing stuff harder and harder. One important piece of the solution is a new generation of intelligent farm equipment that uses artificial intelligence to guide everything from when to plant to when to fertilize. At the moment, though, I like CNH more on price. CNH, the #2 farm equipment maker, is invitingly attractive because it is so cheap, absolutely and in comparison to Deere.
November 3, 2024 | Daily JAM, FTNT, Jubak Picks, PANW, Stock Alerts |
Today I added Fortinet (FTNT) as Pick #6 for my Special Report “10 new stock ideas for an old rally.” I also added the stock to my Jubak Picks Portfolio. Here’s what I wrote:
There’s a long-term buying cycle in the firewall cyber security sector.
October 30, 2024 | Daily JAM, LAC, Long Term, Millennial, Stock Alerts |
Yesterday, Lithium Americas (LCA) announced that it had closed a $2.26 billion loan from the U.S. Department of Energy’s Loan Programs Office under the Advanced Technology Vehicles Manufacturing Loan Program. The funding is earmarked for the construction of processing facilities at the Thacker Pass lithium project in Humboldt County, Nevada. Thacker Pass is currently North America’s largest known lithium resource. The stock jumped almost 5% yesterday on the news. It fell 8.87% today to $4.11 a share. Lithium Americas is a member of my Millennial Portfolio.
October 17, 2024 | Daily JAM, Stock Alerts, Top 50 Stocks, TSM |
Shares of global chipmaking powerhouse rose 9.79% today to hit a record high after the chipmaker topped quarterly estimates and raised its target for 2024 revenue growth. The company—-the main chip manufacturer for Nvidia (NVDA) and Apple (AAPL)–expects sales to climb roughly 30% in U.S. dollar terms this year, up from previous projections for an increase in the mid-20% range. Taiwan’s largest company had raised its outlook for 2024 revenue just a few months ago in July.
October 15, 2024 | ASML, Daily JAM, Jubak Picks, NVDA, Stock Alerts, Top 50 Stocks |
I think the only important investing question for Nvidia (NVDA) is whether you want to buy it on the dip for along-term score or whether you want to sell when the stock bounces to a record high and then re-buy on the next dip? In my portfolios I’ve got both a one-term position in my 50 Stocks Portfolio, up 182% since December 7, 2023, and a more trading oriented position in my 12-18 month Jubak Picks Portfolio, where the position is up 22% since September 6 even with today’s loss. The stock was up 16% in the last month as of the October 14 close
September 17, 2024 | Daily JAM, Jubak Picks, Long Term, MSFT, Stock Alerts, Top 50 Stocks |
Microsoft (MSFT) raised its quarterly dividend by 10% and unveiled a new $60 billion stock-buyback program, matching the size of a repurchase plan three years ago. Shares were up as much as 2.4% today, September 17, before closing ahead 0.87%.
September 12, 2024 | Daily JAM, Long Term, Morning Briefing, SCCO, Stock Alerts, Top 50 Stocks |
China’s copper imports in August dropped by 12.3% from the previous year, preliminary official Chinese customs data showed on Tuesday, September 10. It’s yet another sign that the slowdown in Chinese economy is rippling out into the global economy.
September 7, 2024 | AAPL, Daily JAM, Stock Alerts, Top 50 Stocks |
There’s a good possibility of an AI “nothing-burger” from Apple (AAPL) on Monday, September 9, when the company rolls out its latest iPhones. Which are supposed to mark Apple’s advent as a serious smartphone AI player. All indications are, however, that Apple’s AI features on the iPhone will be distinctly underwhelming. And that’s a potential problem for the stock-up 15.08% for 2024 and ahead 13.67% for the last three months as of the close on September 6.
September 5, 2024 | Daily JAM, Dividend Income, Morning Briefing, Stock Alerts |
Kenvue (KVUEO) isn’t exactly new. As a stand-alone stock, Kenvue dates back only to May 2023, but the company is a spin off of Johnson & Johnson’s (JNJ) consumer division. The owner of household consumer names that include Tylenol, Nicorette, Listerine, and Zyrtec, Kenvue is the world’s largest pure-play consumer health company by sales. The stock closed on September 5 with a yield of 3.64%. Morningstar calculates that the shares are 16% undervalued and puts a $26 target price on the shares. The stock closed at $22.51 on September 5. I’m adding the stock to my Dividend Portfolio tomorrow. With the Federal Reserve extremely like to begin cutting interest rates at its September 18 meeting, a lot of investors are looking for higher yield with slid safety. I think Kenvue offers exactly that combination.
August 26, 2024 | Daily JAM, GDX, GLD, GOLD, Jubak Picks, Mid Term, Morning Briefing, NEM, Perfect Five-ETFs, Stock Alerts, Volatility |
Gold hit a new all-time high today of $2554 an ounce on the Comex for December delivery. Gold’s 20% or so gain in 2024 to date (as of August 26) is a result of strong central-bank buying plus Asian purchases plus anticipation that the Federal Reserve was about to cut interest rates. Now that Fed chair Jerome Powell has just about promised a cut at the Fed’s September 18 meeting it looks like gold will climb further in 2024 on the fundamentals. Bullish Wall Street targets say $2700 to $3,000 by the end of 2024. That’s a decent reason to hold gold. But the very scary geopolitical landscape over the next six months makes me anxious to add more gold even at the record nominal high for the metal.
July 25, 2024 | Daily JAM, Jubak Picks, LLY, NVO, Stock Alerts, VKTX |
Viking Therapeutic (VKTX) has announced that its subcutaneous obesity drug candidate VK2735 is moving into Phase III development. Viking is currently preparing for an end-of-Phase II meeting with the Food & Drug Administration later this year. Just as significant–maybe more?–pharmacokinetics data for VK2735 continues to show the potential for once-a-month dosing. The market-leading GLP diabetes/weight-loss drugs from Eli Lilly (LLY) and Novo Nordisk (NVO) require weekly injections. That dosing advantage gives VK2735 the potential to be the best-in-class obesity drug. (Viking is also at work on an oral version of the drug.)
July 25, 2024 | BYDDF, Daily JAM, Stock Alerts |
Shares of Tesla (TSLA) fell 12.3% Wednesday July 24, after the company delivered bad financial news in its second quarter earnings report. If you own Tesla or are thinking of buying the shares on this tumble, or indeed you own any stock in the current market, you need to understand the exact nature of Tesla’s troubles.
